|
TM9SF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.057480E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.682100E-03 |
| Normal-vs-Stage2 |
2.850000E-02 |
| Normal-vs-Stage3 |
5.832400E-01 |
| Normal-vs-Stage4 |
1.767840E-01 |
| Stage1-vs-Stage2 |
6.702600E-01 |
| Stage1-vs-Stage3 |
2.875800E-01 |
| Stage1-vs-Stage4 |
7.717600E-01 |
| Stage2-vs-Stage3 |
2.236600E-01 |
| Stage2-vs-Stage4 |
9.827000E-01 |
| Stage3-vs-Stage4 |
3.680200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.081700E-03 |
| Normal-vs-AfricanAmerican |
1.141940E-02 |
| Normal-vs-Asian |
3.132400E-01 |
| Caucasian-vs-AfricanAmerican |
8.473400E-01 |
| Caucasian-vs-Asian |
7.133400E-01 |
| AfricanAmerican-vs-Asian |
7.114600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.70499999999829E-05 |
| Normal-vs-Female |
7.461600E-01 |
| Male-vs-Female |
3.313600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.505710E-02 |
| Normal-vs-Extreme_Weight |
3.623100E-04 |
| Normal-vs-Obese |
1.861600E-01 |
| Normal-vs-Extreme_Obese |
5.065900E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.947000E-01 |
| Normal_Weight-vs-Obese |
3.212400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.666200E-01 |
| Extreme_Weight-vs-Obese |
1.121210E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.150600E-01 |
| Obese-vs-Extreme_Obese |
2.667600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.972000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.510200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.63699999999568E-05 |
| Normal-vs-Age(81-100Yrs) |
2.715000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.124200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.633200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.744430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.472480E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.864200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.028800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.718100E-02 |
| Normal-VS-Type2 PRCC |
8.30800000000131E-05 |
| Normal-VS-KIRP CIMP |
5.883400E-01 |
| Normal-VS-Unclassified PRCC |
9.512200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.359700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.392000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.785200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.398400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.889000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.992000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.559350E-03 |
| Normal-vs-N1 |
6.851800E-01 |
| Normal-vs-N2 |
9.81369999999426E-05 |
| N0-vs-N1 |
1.090650E-01 |
| N0-vs-N2 |
3.196200E-01 |
| N1-vs-N2 |
1.298980E-01 |
|
|
